| abstract |
Diphenylaminopyrimidine compounds used to inhibit kinase activity. The present invention provides a pharmaceutical composition of a substituted diphenylaminopyrimidine compound and use thereof, wherein the compound is a compound represented by formula (I), or a pharmaceutically acceptable salt, prodrug, hydrate or Solvates, crystalline forms, N-oxides and various diastereomers. The compounds of the present invention are useful in the treatment of diseases treatable with JAK2 kinase inhibitors. |